Get Ready for the Once-Monthly Injectable HIV Med, Cabenuva

Cabenuva (cabotegravir/rilpivirine) will be the first INJECTABLE antiretroviral for adults with HIV.

It's a complete two-med HIV regimen that is given MONTHLY...and seems to maintain viral load suppression similar to standard 3-drug oral DAILY regimens (Triumeq, etc).

Cabenuva contains one vial of the new integrase inhibitor cabotegravir...and one vial of the non-nucleoside inhibitor rilpivirine.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote